drugset / Trial / NCT06596122

Vitamin D Supplementation in Breast Cancer Patients

NCT06596122

Phase 2 Not yet recruiting 132 enrolled Abdelrahman Mahmoud
RandomizedParallel-groupSingle-blindPrevention

Summary

It is a randomized clinical trial aimed at exploring the neuroprotective effect of vitamin D3 (Cholecalciferol) supplementation in conjunction with paclitaxel-based chemotherapy among breast cancer patients with vitamin D insufficiency or deficiency.

Timeline

Start
2024-10-15
Primary completion
2026-11-30
Completion
2026-12-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 100000 iu Oral

Indications